# Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

> **NCT03241459** · NA · COMPLETED · sponsor: **SurModics, Inc.** · enrollment: 446 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Peripheral Vascular Disease
- Artery Disease, Peripheral
- Femoropopliteal Artery Occlusion

## Interventions

- **DEVICE:** Surmodics SurVeil DCB
- **DEVICE:** Medtronic IN.PACT Admiral DCB

## Key facts

- **NCT ID:** NCT03241459
- **Lead sponsor:** SurModics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-23
- **Primary completion:** 2020-09-15
- **Final completion:** 2024-09-17
- **Target enrollment:** 446 (ACTUAL)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03241459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03241459, "Safety and Efficacy of the SurVeil™ Drug-Coated Balloon". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03241459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*